Medicines R Us Limited - Abbreviated accounts 16.3

Medicines R Us Limited - Abbreviated accounts 16.3

MEDICINES R US LIMITED - Company Information

Print Friendly Version

07258925 1.6.15 31.5.16 31.5.16 Company accounts Private Limited Company FY true false true false false true false true false Ordinary 1.00000 iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure072589252015-05-31072589252016-05-31072589252015-06-012016-05-31072589252014-05-31072589252014-06-012015-05-31072589252015-05-3107258925ns12:England2015-06-012016-05-3107258925ns14:PoundSterling2015-06-012016-05-3107258925ns7:Director12015-06-012016-05-3107258925ns7:OrdinaryShareClass12015-06-012016-05-3107258925ns7:Director22015-06-012016-05-3107258925ns7:Director32015-06-012016-05-3107258925ns7:Director42015-06-012016-05-3107258925ns7:Director52015-06-012016-05-3107258925ns7:RegisteredOffice2015-06-012016-05-3107258925ns5:LandBuildingsns5:ShortLeaseholdProperties2015-06-012016-05-3107258925ns5:FixturesFittings2015-06-012016-05-3107258925ns5:FixedAssetInvestmentsOtherThanLoans2016-05-3107258925ns5:FixedAssetInvestmentsOtherThanLoans2015-05-3107258925ns7:OrdinaryShareClass12016-05-3107258925ns7:OrdinaryShareClass12015-05-31
REGISTERED NUMBER: 07258925 (England and Wales)















Abbreviated Unaudited Accounts for the Year Ended 31 May 2016

for

Medicines R Us Limited

Medicines R Us Limited (Registered number: 07258925)






Contents of the Abbreviated Accounts
for the Year Ended 31 May 2016




Page

Company Information 1

Abbreviated Balance Sheet 2

Notes to the Abbreviated Accounts 4

Medicines R Us Limited

Company Information
for the Year Ended 31 May 2016







DIRECTORS: Dr S R Blake
Dr J L Howe
Dr M C Jarvis
Mrs G Sharma
A K Sharma





REGISTERED OFFICE: Audit House
260 Field End Road
Eastcote
Middlesex
HA4 9LT





REGISTERED NUMBER: 07258925 (England and Wales)





Page 1
Medicines R Us Limited (Registered number: 07258925)

Abbreviated Balance Sheet
31 May 2016

31.5.16 31.5.15
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 2 14,175 17,718
Investments 3 100 100
14,275 17,818

CURRENT ASSETS
Stocks 22,580 23,891
Debtors 217,479 260,906
Cash at bank and in hand 116,918 91,923
356,977 376,720
CREDITORS
Amounts falling due within one year 247,860 277,615
NET CURRENT ASSETS 109,117 99,105
TOTAL ASSETS LESS CURRENT
LIABILITIES
123,392
116,923

CAPITAL AND RESERVES
Called up share capital 4 100 100
Profit and loss account 123,292 116,823
SHAREHOLDERS' FUNDS 123,392 116,923

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31 May 2016.

The members have not required the company to obtain an audit of its financial statements for the year ended 31 May 2016 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act
2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of
each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394
and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial
statements, so far as applicable to the company.

The notes form part of these abbreviated accounts

Page 2 continued...
Medicines R Us Limited (Registered number: 07258925)

Abbreviated Balance Sheet - continued
31 May 2016


The abbreviated accounts have been prepared in accordance with the special provisions of Part 15 of the Companies Act 2006 relating to small companies.


The financial statements were approved by the Board of Directors on 22 February 2017 and were signed on its behalf by:





A K Sharma - Director


The notes form part of these abbreviated accounts

Page 3
Medicines R Us Limited (Registered number: 07258925)

Notes to the Abbreviated Accounts
for the Year Ended 31 May 2016

1. ACCOUNTING POLICIES

Accounting convention
The financial statements have been prepared under the historical cost convention and in accordance with the
Financial Reporting Standard for Smaller Entities (effective January 2015).

Turnover
Turnover represents net invoiced sales of goods, excluding value added tax.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off each asset over its estimated useful life.

Short leasehold - 10% on cost
Fixtures and fittings - 25% on cost

Stocks
Stocks are valued at the lower of cost and net realisable value, after making due allowance for obsolete and slow
moving items.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the balance
sheet date.

Hire purchase and leasing commitments
Rentals paid under operating leases are charged to the profit and loss account on a straight line basis over the period
of the lease.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the company's pension
scheme are charged to the profit and loss account in the period to which they relate.

2. TANGIBLE FIXED ASSETS
Total
£   
COST
At 1 June 2015
and 31 May 2016 36,454
DEPRECIATION
At 1 June 2015 18,736
Charge for year 3,543
At 31 May 2016 22,279
NET BOOK VALUE
At 31 May 2016 14,175
At 31 May 2015 17,718

Page 4 continued...
Medicines R Us Limited (Registered number: 07258925)

Notes to the Abbreviated Accounts - continued
for the Year Ended 31 May 2016

3. FIXED ASSET INVESTMENTS
Investments
other
than
loans
£   
COST
At 1 June 2015
and 31 May 2016 100
NET BOOK VALUE
At 31 May 2016 100
At 31 May 2015 100

4. CALLED UP SHARE CAPITAL

Allotted, issued and fully paid:
Number: Class: Nominal 31.5.16 31.5.15
value: £    £   
100 Ordinary £1 100 100

5. ULTIMATE PARENT COMPANY

Medicines 4U Limited is regarded by the directors as being the company's ultimate parent company.

Page 5